IRIS
TOMMASINI, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.707
NA - Nord America 6.610
AS - Asia 3.987
SA - Sud America 1.252
AF - Africa 124
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.504
RU - Federazione Russa 3.736
SG - Singapore 1.669
CN - Cina 1.144
BR - Brasile 1.096
IE - Irlanda 1.008
SE - Svezia 851
UA - Ucraina 498
HK - Hong Kong 446
DE - Germania 412
VN - Vietnam 269
GB - Regno Unito 248
IT - Italia 246
FI - Finlandia 233
FR - Francia 213
IN - India 130
PL - Polonia 74
AT - Austria 60
AR - Argentina 53
BD - Bangladesh 49
CA - Canada 48
TR - Turchia 40
MX - Messico 35
IQ - Iraq 34
ZA - Sudafrica 31
EC - Ecuador 27
MA - Marocco 26
CI - Costa d'Avorio 24
ES - Italia 23
ID - Indonesia 23
JP - Giappone 23
NL - Olanda 21
PK - Pakistan 20
UZ - Uzbekistan 20
VE - Venezuela 20
BE - Belgio 18
CZ - Repubblica Ceca 17
IR - Iran 16
CO - Colombia 14
AZ - Azerbaigian 13
CL - Cile 13
TN - Tunisia 13
UY - Uruguay 10
IL - Israele 9
KE - Kenya 9
MY - Malesia 9
NP - Nepal 9
AU - Australia 8
JM - Giamaica 8
PE - Perù 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
EG - Egitto 6
ET - Etiopia 6
OM - Oman 6
PH - Filippine 6
DZ - Algeria 5
LT - Lituania 5
LV - Lettonia 5
PS - Palestinian Territory 5
RS - Serbia 5
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
KR - Corea 4
KZ - Kazakistan 4
NO - Norvegia 4
RO - Romania 4
SA - Arabia Saudita 4
AL - Albania 3
PT - Portogallo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IS - Islanda 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 19.682
Salva come PNG Salva come JPEG
Città #
Moscow 1.112
Dublin 1.008
Jacksonville 949
Singapore 870
Ashburn 845
Chandler 659
Nyköping 502
Dallas 473
Hong Kong 445
Beijing 356
San Jose 306
Dearborn 203
The Dalles 174
Princeton 166
Cambridge 161
Los Angeles 161
Medford 152
Lauterbourg 144
Dong Ket 140
Des Moines 125
Boardman 110
Messina 92
Ann Arbor 83
Buffalo 82
São Paulo 77
New York 76
Lancaster 70
Warsaw 66
Tianjin 65
Jinan 58
Vienna 57
Munich 54
Guangzhou 53
Ho Chi Minh City 52
Woodbridge 51
Wilmington 49
Turku 42
San Mateo 41
Shenyang 40
Pune 38
Council Bluffs 37
Redondo Beach 35
Rio de Janeiro 35
Orem 31
Helsinki 29
Belo Horizonte 28
Chennai 28
Hangzhou 28
Brooklyn 27
Brasília 26
Houston 26
Nanjing 26
Abidjan 24
Augusta 24
Frankfurt am Main 24
Montreal 24
Atlanta 23
Tokyo 21
Bremen 20
Campinas 20
Hanoi 20
Nanchang 20
Santa Clara 20
Haikou 19
Shanghai 19
Tashkent 19
Brussels 18
Johannesburg 18
Leawood 18
Chicago 16
London 16
Shenzhen 16
Boston 15
Denver 15
Mumbai 15
Poplar 15
Zhengzhou 15
Curitiba 14
Hebei 14
Phoenix 14
Porto Alegre 14
Salvador 14
Seattle 14
Ankara 13
Brno 13
San Francisco 13
Stockholm 13
Amsterdam 12
Baku 12
Manchester 12
Milan 12
Ningbo 12
Nuremberg 12
Ardabil 11
Baghdad 10
Casablanca 10
Guarulhos 10
Manaus 10
Mexico City 10
Bexley 9
Totale 11.315
Salva come PNG Salva come JPEG
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 265
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 255
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 225
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 203
Anticonvulsant agent: enhancement of physicochemical properties 201
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 195
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 194
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 192
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 184
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 181
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 180
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 178
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 172
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 172
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 171
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 171
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 167
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 167
Analytical profile and release of lonidamine from pharmaceutical formulation 167
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 166
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 166
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 163
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 163
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 162
Chitosan nanospheres containing cyclodextrins for idebenone delivery 161
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 159
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 158
B-Cyclodextrin conjugates for sustained release of drugs 156
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 155
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 155
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 155
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 154
Nanotherapeutics for anti-inflammatory delivery 154
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 153
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 152
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 152
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 152
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 151
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 151
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 148
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 147
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 147
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 144
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 144
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 143
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 142
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 141
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 139
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 138
Biodegradable microparticles as carrier for moxifloxacine 136
BIODEGRADABLE MICROSPHERES FOR INTRAARTICULAR ADMINISTRATION OF CELECOXIB 136
null 135
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 135
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 135
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 134
Determination of fludarabine in a pharmaceutical formulation by LC 134
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 132
Phase solubility and FTIR-ATR studies of idebenone/sulfobutyl ether b-cyclodextrin inclusion complex 129
Structural and spectroscopic features of lutein/butanoyl-beta-cyclodextrin nanoassemblies 128
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 128
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 127
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 123
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 121
Study of the inclusion complex of atenolol with beta- cyclodextrins 121
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 120
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 120
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 119
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 118
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 118
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 117
New formulation of cyclodextrin nanoassemblies as delivery system for idebenone 117
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 116
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 115
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 115
null 115
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 114
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 114
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 114
Solid-state study of polymorphic drugs: carbamazepine 112
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 112
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 111
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 108
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 108
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 107
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 106
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 106
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 105
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 104
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 103
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 103
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 102
Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate 101
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 100
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies 100
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 100
Interaction of a functionalized complex of the flavonoid hesperetin with the AhR pathway and CYP1A1 expression: involvement in its protective effects against benzo[a]pyrene-induced oxidative stress in human skin. 100
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 99
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 98
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
Totale 14.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20253.041 48 51 59 192 113 67 40 694 756 187 283 551
2025/20268.570 426 487 579 631 729 2.007 1.145 984 997 319 123 143
2026/202784 84 0 0 0 0 0 0 0 0 0 0 0
Totale 19.824